Association between CTLA-4 Gene Promoter Region Polymorphisms at Positions -1661 and -318 and Gastric Cancer

LI Rui,XIA Bing,XIAO Hui,JIANG Yi,ZHOU Feng

DOI: https://doi.org/10.3969/j.issn.1008-7125.2009.06.004

2009-01-01

Abstract:Cytotoxic T-lymphocyte-associated antigen-4(CTLA-4) is a potent immunoregulatory molecule that suppresses antitumor immunoreaction by down-regulating T-cell activation.Aims:To investigate the association between CTLA-4 gene promoter region polymorphisms at positions -1661 and -318 and gastric cancer.Methods:Unrelated 121 gastric cancer patients and 236 healthy controls were enrolled in this study.Polymerase chain reaction-restriction fragment length polymorphism(PCR-RFLP) and amplification refractory mutation system(ARMS)-PCR were used to assess CTLA-4 gene promoter region polymorphisms at positions -1661 and -318,respectively.Results:The frequencies of AA genotype and A allele at position -1661 were statistically lower in gastric cancer patients than in healthy controls(73.6%vs.83.9%, P=0.024;85.1%vs.91.1%,P=0.022).The frequencies of CC genotype and C allele at position -318 were not significantly different between gastric cancer patients and healthy controls.Both the frequencies of AA genotype at position -1661 and CC genotype at position -318 were statistically lower in tubular adenocarcinoma patients than in healthy controls(64.1% vs.83.9%,P=0.001;76.6%vs.87.3%,P=0.047).Conclusions:CTLA-4 gene promoter region polymorphism at position -1661 shows a significantly negative association with gastric cancer,while those at positions -1661 and -318 show a significantly negative association with tubular adenocarcinoma.